A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
Go Omniglass with Swoop’s TV marketing solutions. Bridge audience fragmentation and maximize your TV strategy across leading channel partners with our omniglass offering.
Unlock your brand.com first-party data potential. Swoop’s award winning chatbot transforms site level engagement into valuable first-party data with conversational AI.
Honored by innovation awards from the BIG and PM360, Swoop’s predictive audiences showcase how pharmaceutical marketing can help improve patient’s health outcomes.
Accessible exclusively through the company’s proprietary GenAI platform Swoop Piper, these AI Assistants represent a new frontier in healthcare marketing.
Celebrating the innovative and impactful use of conversational AI technology, CUSTOMER magazine awarded Swoop a 2024 Conversational AI Excellence Award.
Swoop's new conversational AI platform allows pharma brands to engage in 24/7, MLR-compliant near-human interaction with ideal customers in the moment of need.